Queensland Brain Institute (QBI) Professor Peter Silburn AM said his team, together with Neurosciences Queensland and Abbott Neuromodulation have developed a remote care platform which allows patients to access treatment from anywhere in the world.
“By creating the world’s first integrated and completely wireless remote care platform, we have removed the need for patients to see their doctor in person to have their device adjusted,” Professor Silburn said.
Electrodes are surgically inserted into the brain and electrical stimulation is delivered by a pacemaker which alters brain function - providing therapeutic relief and improving quality of life.
This digital platform allows clinicians to monitor patients remotely, as well as adjust the device to treat and alleviate symptoms in real time.
“We have shown that it is possible to minimize disruption to patients’ and caregivers’ lifestyles by increasing accessibility to the service, saving time and money,” Professor Silburn said.
“There are no cures for many of these conditions which often require life-long treatment and care, so for those people the device would be a game-changer.”
He said the system also fostered increasingly personalized treatment and data-driven clinical decisions, which could improve patient care.